A rare case of histologically mixed-type intramucosal gastric cancer accompanied by nodal recurrence and liver metastasis after endoscopic submucosal dissection

Gastrointestinal Endoscopy

Volumn 69, Issue 3, 2009, Pages 588-590

  Hanaoka, Noboru ^a   Tanabe, Satoshi ^a   Higuchi, Katsuhiko ^a   Sasaki, Tohru ^a   Nakatani, Kento ^a   Ishido, Kenji ^a   Ae, Takako ^a   Koizumi, Wasaburo ^a   Saigenji, Katsunori ^a   Mikami, Tetuo ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; IRINOTECAN; PACLITAXEL;

ADULT; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; DISSECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INTESTINE MUCOSA; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; OUTPATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH MUSCLE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR BIOPSY;

ADENOCARCINOMA; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS;

EID: 60149103023     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.05.030     Document Type: Article

References (14)

1. Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3 (2000) 219-225
2. Koizumi W., Kurihara M., Nakano S., et al. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology 58 (2000) 191-197
3. Boku N., Ohtsu A., Shimada Y., et al. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 17 (1999) 319-323
4. Koizumi W., Tanabe S., Higuchi K., et al. Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer. Anticancer Res 26 (2006) 3797-3802
5. Yamao T., Shirao K., Ono H., et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 77 (1996) 602-606
6. Chang Y.C., Nagasue N., Abe S., et al. Alpha fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 32 (1991) 542-545
7. Hirasaki S., Tanimizu M., Tsuzuki T., et al. Seronegative alpha-fetoprotein-producing early gastric cancer treated with endoscopic mucosal resection and additional surgery. Intern Med 43 (2004) 926-930
8. Tsuji N., Ishiguro S., and Suzuki N. Risk factors for lymph node metastasis of intramucosal gastric cancer: a case control study. [in Japanese with an English abstract]. Gastroenterol Endosc 41 (1999) 1059-1065
9. Hirohashi S., and Sugimura T. Genetic alterations in human gastric cancer. Cancer Cells 3 (1991) 49-52
10. Aoyagi K., Koufuji K., Yano S., et al. A case of small mucosal gastric carcinoma with lymph node metastasis. Kurume Med J 50 (2003) 49-51
11. Koseki K., Takizawa T., Koike M., Ito M., Nihei Z., and Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 89 (2000) 724-732
12. Kabashima A., Yao T., Maehara Y., et al. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas. Gastric Cancer 8 (2005) 220-227
13. Kushima R., and Hattori T. Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120 (1993) 103-111
14. Yoshikawa A., Inada K., Yamachika T., et al. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1 (1998) 134-141